Abingdon Health (ABDX)

Sector:

Health Care

Index:

FTSE AIM All-Share

10.75p
   
  • Change Today:
      0.75p
  • 52 Week High: 62.31
  • 52 Week Low: 7.75
  • Currency: UK Pounds
  • Shares Issued: 121.71m
  • Volume: 279,813
  • Market Cap: £13.08m

Abingdon Health FY revenues at bottom end of guidance

By Iain Gilbert

Date: Wednesday 27 Oct 2021

LONDON (ShareCast) - (Sharecast News) - Covid-19 test kit manufacturer Abingdon Health warned on Thursday that full-year revenues would be at the bottom end of forecasts.
Abingdon Health recorded an adjusted underlying loss of £3.3m for the year ended 30 June, in line with previous guidance, while full-year revenues were roughly £11.6m, up from £5.2m a year earlier.

However, despite the marked increase in revenues, the result was still at the lower end of forecasts, which originally had revenues pegged to be somewhere in the range of £11.4m to £17.0m.

The AIM-listed group said it had been encouraged by ongoing discussions regarding its AbC-19 test kit and added that it was continuing to work on registering the product in a range of territories but Abingdon stated it had seen no "significant commercial traction" thus far.

Chief executive Chris Yates said: "Abingdon continues to see material opportunities for the AbC-19 rapid test both in the UK and internationally and we anticipate the onus switching to a more integrated testing approach which utilises the potential cost and practical benefits of neutralising antibody testing alongside both PCR and antigen testing."

As of 1210 BST, Abingdon shares had slumped 20.54% to 29.40p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

ABDX Market Data

Currency UK Pounds
Share Price 10.75p
Change Today 0.75p
% Change 7.50 %
52 Week High 62.31
52 Week Low 7.75
Volume 279,813
Shares Issued 121.71m
Market Cap £13.08m

ABDX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
57.54% above the market average57.54% above the market average57.54% above the market average57.54% above the market average57.54% above the market average
38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average
Price Trend
82.99% below the market average82.99% below the market average82.99% below the market average82.99% below the market average82.99% below the market average
65.85% below the sector average65.85% below the sector average65.85% below the sector average65.85% below the sector average65.85% below the sector average
Income Not Available
Growth
20.13% above the market average20.13% above the market average20.13% above the market average20.13% above the market average20.13% above the market average
22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average

ABDX Dividends

No dividends found

Trades for 27-May-2022

Time Volume / Share Price
16:29 488 @ 10.88p
16:22 23,567 @ 10.88p
16:19 15,500 @ 10.90p
16:18 2,500 @ 10.90p
16:15 42,297 @ 10.75p

ABDX Key Personnel

CEO Chris Henry Francis Yates
CFO Melanie Ross

Top of Page